Literature DB >> 3864577

Comparison of the effects of different anti-inflammatory drugs on synovial fluid prostanoid concentrations in patients with rheumatoid arthritis.

E Seppälä, M Nissilä, H Isomäki, P Nuotio, E Nykänen, O Laitinen, H Vapaatalo.   

Abstract

The effects of one-day treatment with nine nonsteroidal anti-inflammatory drugs and prednisolone on human synovial fluid concentrations of prostanoids were studied. The doses were calculated so as to be approximately equipotent according to clinical experience and the recommendations of the manufacturers. Most of the drugs used reduced clearly PGE2 and TxB2 levels in synovial fluid, but only a slight diminution in 6-keto-PGF1 alpha values was found. Carprofen, diclofenac, indomethacin, naproxen and tolfenamic acid reduced significantly the synovial fluid PGE2 concentrations. Diclofenac and indomethacin also reduced significantly the synovial TxB2 concentrations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3864577     DOI: 10.1007/bf02031615

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

1.  Prostaglandins; their biological and pharmacological role.

Authors:  H Vapaatalo; J Parantainen
Journal:  Med Biol       Date:  1978-08

2.  Cyclic nucleotides and modulation of effector systems of inflammation.

Authors:  M Kaliner; K F Austen
Journal:  Biochem Pharmacol       Date:  1974-02-15       Impact factor: 5.858

Review 3.  Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.

Authors:  W J Wallis; P A Simkin
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

Review 4.  Immunoregulatory activity of metabolites of arachidonic acid and their role in inflammation.

Authors:  G P Lewis
Journal:  Br Med Bull       Date:  1983-07       Impact factor: 4.291

5.  A modified method for extraction and purification of prostaglandins with resin XAD-2.

Authors:  E Seppälä; O Pora; T Metsä-Ketelä
Journal:  Prostaglandins Leukot Med       Date:  1984-05

6.  Differences in the production of arachidonic acid metabolites between healthy and rheumatic synovial fibroblasts in vitro. A preliminary study.

Authors:  P Pietilä; E Moilanen; E Seppälä; M Nissilä; P Lepistö; O Laitinen; H Vapaatalo
Journal:  Scand J Rheumatol       Date:  1984       Impact factor: 3.641

7.  Effects of nonsteroidal anti-inflammatory drugs on rat gastric mucosal phosphodiesterase activity.

Authors:  J Silvola; M Kangasaho; O Tokola; H Vapaatalo
Journal:  Agents Actions       Date:  1982-10

8.  Comparison of the analgesic effect of ten nonsteroidal anti-inflammatory drugs.

Authors:  H Isomäki; J Martio; K Kaarela; A Kajander; K Koota; K Lehtinen; R Luukkainen; T Martio; M Nissilä; P Nuotio
Journal:  Br J Rheumatol       Date:  1984-02

9.  Plasma levels and urinary excretion of prostaglandins in patients with rheumatoid arthritis.

Authors:  O Laitinen; E Seppalä; M Nissilä; H Vapaatalo
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

10.  Prostaglandin production by rheumatoid synovial cells: stimulation by a factor from human mononuclear Cells.

Authors:  J M Dayer; D R Robinson; S M Krane
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

Review 2.  A comparison of synovial fluid concentrations of non-steroidal anti-inflammatory drugs with their in vitro activity.

Authors:  E Urquhart
Journal:  Agents Actions       Date:  1991-03

3.  Cyclic adenosine 5'-monophosphate in synovial fluid of rheumatoid arthritis and osteoarthritis patients.

Authors:  Jadranka Morovic-Vergles; Melanie Ivana Culo; Stjepan Gamulin; Filip Culo
Journal:  Rheumatol Int       Date:  2008-08-10       Impact factor: 2.631

4.  Effect of diclofenac on prostaglandin E and hyaluronic acid production by human synovial fibroblasts stimulated with interleukin-1.

Authors:  F A Meyer; I Yaron; V Mashiah; M Yaron
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

Review 5.  Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states.

Authors:  P A Todd; S P Clissold
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

6.  Orally administered tolfenamic acid inhibits leukotriene synthesis in isolated human peripheral polymorphonuclear leukocytes.

Authors:  E Moilanen; J Alanko; A Juhakoski; H Vapaatalo
Journal:  Agents Actions       Date:  1989-08

Review 7.  The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.

Authors:  Garry G Graham; Michael J Davies; Richard O Day; Anthoulla Mohamudally; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2013-05-30       Impact factor: 4.473

8.  Effect of misoprostol on concentrations of prostaglandins in synovial fluid.

Authors:  A Doube; J Davies; L Notarianni; K Holgate; G C Fenn
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 9.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 10.  A risk-benefit appraisal of injectable NSAIDs in the management of postoperative pain.

Authors:  L S Nuutinen; J O Laitinen; T E Salomäki
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.